Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Matthew D BensonDavid J A PlemelElaine YacyshynIrwindeep SandhuIan M MacDonaldChad F BakerPublished in: Ocular immunology and inflammation (2019)
Combined rituximab and bortezomib treatment did not result in significant clinical improvement and there was evidence of disease progression. Further prospective studies are required to assess the efficacy of immunotherapy in patients with autoimmune retinopathy.